These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19647614)

  • 1. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer with peritoneal surface disease.
    Shen P; Stewart JH; Levine EA
    Curr Probl Cancer; 2009; 33(3):154-67. PubMed ID: 19647614
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
    Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
    J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.
    Esquivel J; Piso P; Verwaal V; Bachleitner-Hofmann T; Glehen O; González-Moreno S; Deraco M; Pelz J; Alexander R; Glockzin G
    J Surg Oncol; 2014 Dec; 110(7):777-8. PubMed ID: 25043759
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications.
    Shen P; Stewart JH; Levine EA
    Curr Probl Cancer; 2009; 33(3):168-93. PubMed ID: 19647615
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
    Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
    World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
    J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Ann Surg Oncol; 2013 Dec; 20(13):4183-9. PubMed ID: 23975316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH; Rasmussen PC; Laurberg S
    Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy.
    Zhou S; Feng Q; Zhang J; Zhou H; Jiang Z; Liu Z; Zheng Z; Chen H; Wang Z; Liang J; Pei W; Liu Q; Zhou Z; Wang X
    BMC Cancer; 2021 Jan; 21(1):41. PubMed ID: 33413223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
    Jeon Y; Park EJ; Lim JH; Baik SH
    World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
    Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG
    Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.
    Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N
    World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.
    Arjona-Sanchez A; Rodriguez-Ortiz L; Baratti D; Schneider MA; Gutiérrez-Calvo A; García-Fadrique A; Tuynman JB; Cascales-Campos PA; Martín VC; Morales R; Salti GI; Arteaga X; Pacheco D; Alonso-Gomez J; Yalkin O; Villarejo-Campos P; Sanchez-Hidalgo JM; Casado-Adam A; Cosano-Alvarez A; Rufian-Peña S; Briceño J
    Ann Surg Oncol; 2019 Aug; 26(8):2595-2604. PubMed ID: 31111351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].
    Glockzin G; Ghali N; Lang SA; Agha A; Schlitt HJ; Piso P
    Chirurg; 2007 Dec; 78(12):1100, 1102-6, 1108-10. PubMed ID: 17992490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin.
    Chang GJ; Lambert LA
    Ann Surg Oncol; 2008 Nov; 15(11):2993-5. PubMed ID: 18787903
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP).
    Cascales-Campos PA; López-López V; Torres-Melero J; Arjona A; Muñoz-Casares FC; Barrios P; Morales R; Pereira F; Bretcha-Boix P; González-Bayón L; González-Moreno S; Gil J
    Clin Transl Oncol; 2020 Jan; 22(1):130-136. PubMed ID: 31049819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
    Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
    Baratti D; Kusamura S; Azmi N; Guaglio M; Montenovo M; Deraco M
    Ann Surg Oncol; 2020 Jan; 27(1):98-106. PubMed ID: 31691116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis.
    van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2015 Apr; 22(4):1236-42. PubMed ID: 25319584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Adjuvant" Hyperthermic Intraperitoneal Chemotherapy: A Call to Action.
    McAuliffe JC; Nash GM
    Ann Surg Oncol; 2017 Jan; 24(1):11-12. PubMed ID: 27510843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.